The rise of Sildenafil initially sparked a boom for pharma, but recent developments present a uncertain scenario for shareholders. Lower-cost competitors are eroding revenue, and persistent litigation add further https://haimacjpk437109.frewwebs.com/40203721/viagra-and-the-pharmaceutical-industry-a-precarious-investment